Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 6/20 | 0.38 |
| ▸ | NPC1 | O15118 | 6/20 | 0.38 |
| ▸ | RAB9A | P51151 | 5/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.38 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.38 |
| ▸ | AHR | P35869 | 1/20 | 0.38 |
| ▸ | CCNB2 | O95067 | 1/20 | 0.35 |
| ▸ | CDK1 | P06493 | 1/20 | 0.35 |
| ▸ | CCNB1 | P14635 | 1/20 | 0.35 |
| ▸ | CCNB3 | Q8WWL7 | 1/20 | 0.35 |
| ▸ | KDM4E | B2RXH2 | 5/20 | 0.33 |
| ▸ | MEN1 | O00255 | 4/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.33 |
| ▸ | HPGD | P15428 | 2/20 | 0.33 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.33 |
| ▸ | GAA | P10253 | 2/20 | 0.33 |
| ▸ | TP53 | P04637 | 1/20 | 0.33 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.33 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.33 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Phenol SCHEMBL7585957 | 0.91 | MEN1 (0.41) | MAPTNPC1RAB9AALDH1A1SMN1; SMN2 | |
| Maleic Acid SCHEMBL28982547 | 0.89 | HSD17B10 (0.38) | MAPTNPC1RAB9AALDH1A1SMN1; SMN2 | |
| SCHEMBL27592760 | 0.79 | MAPT (0.38) | MAPTNPC1RAB9AALDH1A1SMN1; SMN2 | |
| SCHEMBL10983158 | 0.79 | NPC1 (0.38) | MAPTNPC1RAB9AALDH1A1SMN1; SMN2 | |
| SCHEMBL2928380 | 0.79 | MAPT (0.38) | MAPTNPC1RAB9AALDH1A1SMN1; SMN2 | |
| SCHEMBL2501720 | 0.79 | MAPT (0.38) | MAPTNPC1RAB9AALDH1A1SMN1; SMN2 | |
| SCHEMBL31450545 | 0.79 | MAPT (0.38) | MAPTNPC1RAB9AALDH1A1SMN1; SMN2 | |
| Caffeine SCHEMBL27612824 | 0.77 | ADORA2B (0.51) | ALDH1A1SMN1; SMN2KDM4EKMT2APOLB | |
| SCHEMBL6889912 | 0.77 | MAPT (0.36) | MAPTNPC1RAB9AALDH1A1SMN1; SMN2 | |
| SCHEMBL652529 | 0.76 | MAPT (0.39) | MAPTNPC1RAB9AALDH1A1SMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1840 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260000741-A1 | METHOD OF AMELIORATING A PRO-INFLAMMATORY IMMUNOPHENOTYPE IN FARBER DISEASE SUBJECTS BY REPEATED ADMINISTRATION OF A RECOMBINANT HUMAN ACID CERAMIDASE | ACERAGEN INC (US) | 2026-01-01 | — | — | US | claimed |
| US-20250255781-A1 | PROCESSES FOR PREPARATION OF 3-D PRINTED PHARMACEUTICAL PRODUCTS | BRISTOL-MYERS SQUIBB COMPANY (US) | 2025-08-14 | — | — | US | claimed |
| WO-2025111482-A1 | COMPLEXING AGENT SALT FORMULATIONS OF PHARMACEUTICAL COMPOUNDS AT LOW STOICHIOMETRIC RATIOS | BEXSON BIOMEDICAL, INC. (US) | 2025-05-30 | — | — | WO | claimed |
| US-12296043-B2 | Liquisoft capsules | PATHEON SOFTGELS INC. (US) | 2025-05-13 | — | — | US | claimed |
| EP-4510999-A1 | PROCESSES FOR PREPARATION OF 3-D PRINTED PHARMACEUTICAL PRODUCTS | Bristol-Myers Squibb Company (US) | 2025-02-26 | — | — | EP | claimed |
| CN-119212681-A | Method for preparing 3-D printed pharmaceutical products | 百时美施贵宝公司 | 2024-12-27 | — | — | CN | claimed |
| US-20240269115-A1 | PYRAZOLONE COMPOUNDS FOR USE IN DEGENERATIVE RETINAL DISEASES | FLONEXT S.R.L. (IT) | 2024-08-15 | — | — | US | claimed |
| US-20240165020-A1 | LIQUISOFT CAPSULES | PATHEON SOFTGELS INC (US) | 2024-05-23 | — | — | US | claimed |
| WO-2024105529-A1 | CHEMICAL DISBUDDING OF LIVESTOCK | MASSEY UNIVERSITY (NZ) | 2024-05-23 | — | — | WO | claimed |
| EP-4360653-A2 | LIQUISOFT CAPSULES | Patheon Softgels Inc. (US) | 2024-05-01 | — | — | EP | claimed |
| CN-1245686-A | Compound Niuduning oral liquor and its preparation method | SHI DENG (CN) | 2000-03-01 | — | — | CN | claimed |
| CN-1243723-A | Quick-acting analgesic ointment | LU ZIJUN (CN) | 2000-02-09 | — | — | CN | claimed |
| WO-1998052616-A2 | NONSTEROIDAL ANTIRHEUMATIC AGENTS OR THROMBOCYTE-AGGLUTINATION INHIBITORS TO IMPROVE REPRESENTATION OF VESSELS, LYMPH NODES AND BONE MARROW WITH PHARMACEUTICAL PREPARATIONS CONTAINING PARTICLES, VESICLES OF POLYMERS | Institut für Diagnostikforschung GmbH an der Freien Universität Berlin (DE) | 1998-11-26 | — | — | WO | claimed |
| CN-1156961-A | Formulations and method for providing prolonged local anesthesia | EURO CELTIQUE SA (LU) | 1997-08-13 | — | — | CN | claimed |
| CN-1025474-C | Medicine stick therapeutic equipment | XUZHOU HEAVY DUTY MACHINERY PL (CN) | 1994-07-20 | — | — | CN | claimed |
| US-5206006-A | Peroxidase enzyme; phenylpyrazone derivative phenol or aromatic amine; stabilizer; storage discoloration inhibition | INSTRUMENTATION LABORATORY SPA (IT) | 1993-04-27 | — | — | US | claimed |
| EP-0408496-A2 | Solid dosage form for pharmaceutical substances | CIBA-GEIGY AG (CH) | 1991-01-16 | — | — | EP | claimed |
| CN-1037833-A | Medicine-stick therapeutic appliance and cooperating medicinal liquor | XUZHOU HEAVY MACHINERY PLANT (CN) | 1989-12-13 | — | — | CN | claimed |
| EP-0036145-B1 | AN ORALLY ADMINISTERED DRUG FORM COMPRISING A POLAR BIOACTIVE AGENT AND AN ADJUVANT | INTERx RESEARCH CORPORATION (US) | 1985-05-29 | — | — | EP | claimed |
| EP-0007572-A1 | Pharmaceutical mixtures containing an amantadine compound | CIBA-GEIGY AG (CH) | 1980-02-06 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240269115-A1 | PYRAZOLONE COMPOUNDS FOR USE IN DEGENERATIVE RETINAL DISEASES | ALDH1A2, PDK3, EYA3 | MAPT 734/4885NPC1 654/4885RAB9A 2369/4885 |
| US-20260000741-A1 | METHOD OF AMELIORATING A PRO-INFLAMMATORY IMMUNOPHENOTYPE IN FARBER DISEASE SUBJECTS BY REPEATED ADMINISTRATION OF A RECOMBINANT HUMAN ACID CERAMIDASE | ASAH2, ASAH1, GBA2 | MAPT 4462/4885NPC1 155/4885RAB9A 415/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.